APO Research

APO RESEARCH · REPORT

Injections for SMA

Selected research

Industry Growth & Trends

Global Injections for SMA Industry Growth and Trends Forecast to 2032

Market perspective

The global Injections for SMA market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injections for SMA include Novartis, Biogen and Ionis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Injections for SMA market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Injections for SMA market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injections for SMA market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injections for SMA.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Injections for SMA market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Injections for SMA Market by Company

Novartis

Biogen

Ionis Pharmaceuticals

Injections for SMA Segment by Type

Antisense Oligonucleotides

Gene Therapy

Injections for SMA Segment by Application

Hospital

Clinic

Other

Injections for SMA Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injections for SMA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injections for SMA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injections for SMA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injections for SMA manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Injections for SMA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antisense Oligonucleotides Table 2. Major Company of Gene Therapy Table 3. Global Injections for SMA Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Injections for SMA Sales by Type (2021-2026) & (K Units) Table 5. Global Injections for SMA Sales Market Share in Volume by Type (2021-2026) Table 6. Global Injections for SMA Sales by Type (2021-2026) & (US$ Million) Table 7. Global Injections for SMA Sales Market Share in Value by Type (2021-2026) Table 8. Global Injections for SMA Price by Type (2021-2026) & (US$/Unit) Table 9. Global Injections for SMA Sales by Type (2027-2032) & (K Units) Table 10. Global Injections for SMA Sales Market Share in Volume by Type (2027-2032) Table 11. Global Injections for SMA Sales by Type (2027-2032) & (US$ Million) Table 12. Global Injections for SMA Sales Market Share in Value by Type (2027-2032) Table 13. Global Injections for SMA Price by Type (2027-2032) & (US$/Unit) Table 14. North America Injections for SMA Sales by Type (2021-2026) & (K Units) Table 15. North America Injections for SMA Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Injections for SMA Sales by Type (2021-2026) & (K Units) Table 17. Europe Injections for SMA Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Injections for SMA Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Injections for SMA Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Injections for SMA Sales by Type (2021-2026) & (K Units) Table 21. Latin America Injections for SMA Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Injections for SMA Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Injections for SMA Sales by Type (2021-2026) & (US$ Million) Table 24. Injections for SMA Industry Trends Table 25. Injections for SMA Industry Drivers Table 26. Injections for SMA Industry Opportunities and Challenges Table 27. Injections for SMA Industry Restraints Table 28. Global Injections for SMA Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Injections for SMA Revenue Market Share by Company (2021-2026) Table 30. Global Injections for SMA Sales by Company (2021-2026) & (K Units) Table 31. Global Injections for SMA Sales Share by Company (2021-2026) Table 32. Global Injections for SMA Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Injections for SMA Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Injections for SMA Major Company Production Sites and Headquarters Table 35. Global Injections for SMA Company, Product Type & Application Table 36. Global Injections for SMA Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Injections for SMA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Injections for SMA Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Injections for SMA Sales by Region (2021-2026) & (K Units) Table 41. Global Injections for SMA Sales Market Share in Volume by Region (2021-2026) Table 42. Global Injections for SMA Sales by Region (2021-2026) & (US$ Million) Table 43. Global Injections for SMA Sales Market Share in Value by Region (2021-2026) Table 44. Global Injections for SMA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Injections for SMA Sales by Region (2027-2032) & (K Units) Table 46. Global Injections for SMA Sales Market Share in Volume by Region (2027-2032) Table 47. Global Injections for SMA Sales by Region (2027-2032) & (US$ Million) Table 48. Global Injections for SMA Sales Market Share in Value by Region (2027-2032) Table 49. Global Injections for SMA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Injections for SMA Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Injections for SMA Sales by Application (2021-2026) & (K Units) Table 52. Global Injections for SMA Sales Market Share in Volume by Application (2021-2026) Table 53. Global Injections for SMA Sales by Application (2021-2026) & (US$ Million) Table 54. Global Injections for SMA Sales Market Share in Value by Application (2021-2026) Table 55. Global Injections for SMA Price by Application (2021-2026) & (US$/Unit) Table 56. Global Injections for SMA Sales by Application (2027-2032) & (K Units) Table 57. Global Injections for SMA Sales Market Share in Volume by Application (2027-2032) Table 58. Global Injections for SMA Sales by Application (2027-2032) & (US$ Million) Table 59. Global Injections for SMA Sales Market Share in Value by Application (2027-2032) Table 60. Global Injections for SMA Price by Application (2027-2032) & (US$/Unit) Table 61. North America Injections for SMA Sales by Application (2021-2026) & (K Units) Table 62. North America Injections for SMA Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Injections for SMA Sales by Application (2021-2026) & (K Units) Table 64. Europe Injections for SMA Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Injections for SMA Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Injections for SMA Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Injections for SMA Sales by Application (2021-2026) & (K Units) Table 68. Latin America Injections for SMA Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Injections for SMA Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Injections for SMA Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Injections for SMA Product Portfolio Table 75. Novartis Recent Development Table 76. Biogen Company Information Table 77. Biogen Business Overview Table 78. Biogen Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Biogen Injections for SMA Product Portfolio Table 80. Biogen Recent Development Table 81. Ionis Pharmaceuticals Company Information Table 82. Ionis Pharmaceuticals Business Overview Table 83. Ionis Pharmaceuticals Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Ionis Pharmaceuticals Injections for SMA Product Portfolio Table 85. Ionis Pharmaceuticals Recent Development Table 86. North America Injections for SMA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. North America Injections for SMA Sales by Country (2021-2026) & (K Units) Table 88. North America Injections for SMA Sales Market Share by Country (2021-2026) Table 89. North America Injections for SMA Sales Forecast by Country (2027-2032) & (K Units) Table 90. North America Injections for SMA Sales Market Share Forecast by Country (2027-2032) Table 91. North America Injections for SMA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Injections for SMA Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Injections for SMA Market Share by Country (2021-2026) Table 94. North America Injections for SMA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Injections for SMA Market Share Forecast by Country (2027-2032) Table 96. Europe Injections for SMA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Europe Injections for SMA Sales by Country (2021-2026) & (K Units) Table 98. Europe Injections for SMA Sales Market Share by Country (2021-2026) Table 99. Europe Injections for SMA Sales Forecast by Country (2027-2032) & (K Units) Table 100. Europe Injections for SMA Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Injections for SMA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Injections for SMA Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Injections for SMA Market Share by Country (2021-2026) Table 104. Europe Injections for SMA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Injections for SMA Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Injections for SMA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Injections for SMA Sales by Country (2021-2026) & (K Units) Table 108. Asia-Pacific Injections for SMA Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Injections for SMA Sales Forecast by Country (2027-2032) & (K Units) Table 110. Asia-Pacific Injections for SMA Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Injections for SMA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Injections for SMA Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Injections for SMA Market Share by Country (2021-2026) Table 114. Asia-Pacific Injections for SMA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Injections for SMA Market Share Forecast by Country (2027-2032) Table 116. Latin America Injections for SMA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Latin America Injections for SMA Sales by Country (2021-2026) & (K Units) Table 118. Latin America Injections for SMA Sales Market Share by Country (2021-2026) Table 119. Latin America Injections for SMA Sales Forecast by Country (2027-2032) & (K Units) Table 120. Latin America Injections for SMA Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Injections for SMA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Injections for SMA Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Injections for SMA Market Share by Country (2021-2026) Table 124. Latin America Injections for SMA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Injections for SMA Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Injections for SMA Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Injections for SMA Sales by Country (2021-2026) & (K Units) Table 128. Middle East and Africa Injections for SMA Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Injections for SMA Sales Forecast by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Injections for SMA Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Injections for SMA Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Injections for SMA Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Injections for SMA Market Share by Country (2021-2026) Table 134. Middle East and Africa Injections for SMA Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Injections for SMA Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Injections for SMA Distributors List Table 139. Injections for SMA Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Injections for SMA Image Figure 2. Global Injections for SMA Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injections for SMA Market Size (2021-2032) & (US$ Million) Figure 4. Global Injections for SMA Sales (2021-2032) & (K Units) Figure 5. Antisense Oligonucleotides Image Figure 6. Global Antisense Oligonucleotides Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gene Therapy Image Figure 8. Global Gene Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Injections for SMA Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Injections for SMA Market Share by Type 2025 VS 2032 Figure 11. North America Injections for SMA Sales Market Share in Volume by Type in 2025 Figure 12. North America Injections for SMA Sales Market Share in Value by Type in 2025 Figure 13. Europe Injections for SMA Sales Market Share in Volume by Type in 2025 Figure 14. Europe Injections for SMA Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Injections for SMA Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Injections for SMA Sales Market Share in Value by Type in 2025 Figure 17. Latin America Injections for SMA Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Injections for SMA Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Injections for SMA Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Injections for SMA Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Injections for SMA Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Injections for SMA Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Injections for SMA Market Share by Application 2025 VS 2032 Figure 31. North America Injections for SMA Sales Market Share in Volume by Application in 2025 Figure 32. North America Injections for SMA Sales Market Share in Value by Application in 2025 Figure 33. Europe Injections for SMA Sales Market Share in Volume by Application in 2025 Figure 34. Europe Injections for SMA Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Injections for SMA Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Injections for SMA Sales Market Share in Value by Application in 2025 Figure 37. Latin America Injections for SMA Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Injections for SMA Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Injections for SMA Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Injections for SMA Sales Market Share in Value by Application in 2025 Figure 41. North America Injections for SMA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Injections for SMA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Injections for SMA Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Injections for SMA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Injections for SMA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Injections for SMA Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Injections for SMA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Injections for SMA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Injections for SMA Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Injections for SMA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Injections for SMA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Injections for SMA Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Injections for SMA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Injections for SMA Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Injections for SMA Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Injections for SMA Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Injections for SMA Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Antisense Oligonucleotides
  • Gene Therapy
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Biogen
  • Ionis Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injections for SMA Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Injections for SMA Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Injections for SMA Market by Type
  6. 1.3.1 Antisense Oligonucleotides
  7. 1.3.2 Gene Therapy
  8. 1.4 Global Injections for SMA Market Size by Type
  9. 1.4.1 Global Injections for SMA Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Injections for SMA Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Injections for SMA Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Injections for SMA Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Injections for SMA Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Injections for SMA Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Injections for SMA Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Injections for SMA Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Injections for SMA Industry Trends
  2. 2.2 Injections for SMA Industry Drivers
  3. 2.3 Injections for SMA Industry Opportunities and Challenges
  4. 2.4 Injections for SMA Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Injections for SMA Revenue (2021-2026)
  2. 3.2 Global Top Players by Injections for SMA Sales (2021-2026)
  3. 3.3 Global Top Players by Injections for SMA Price (2021-2026)
  4. 3.4 Global Injections for SMA Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injections for SMA Major Company Production Sites & Headquarters
  6. 3.6 Global Injections for SMA Company, Product Type & Application
  7. 3.7 Global Injections for SMA Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injections for SMA Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injections for SMA Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injections for SMA Tier 1, Tier 2, and Tier 3
4 Injections for SMA Regional Status and Outlook
  1. 4.1 Global Injections for SMA Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Injections for SMA Historic Market Size by Region
  3. 4.2.1 Global Injections for SMA Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Injections for SMA Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Injections for SMA Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Injections for SMA Forecasted Market Size by Region
  7. 4.3.1 Global Injections for SMA Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Injections for SMA Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Injections for SMA Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injections for SMA by Application
  1. 5.1 Injections for SMA Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Injections for SMA Market Size by Application
  6. 5.2.1 Global Injections for SMA Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Injections for SMA Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Injections for SMA Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Injections for SMA Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Injections for SMA Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Injections for SMA Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Injections for SMA Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Injections for SMA Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Injections for SMA Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Injections for SMA Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Injections for SMA Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biogen Injections for SMA Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Ionis Pharmaceuticals
  14. 6.3.1 Ionis Pharmaceuticals Company Information
  15. 6.3.2 Ionis Pharmaceuticals Business Overview
  16. 6.3.3 Ionis Pharmaceuticals Injections for SMA Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ionis Pharmaceuticals Injections for SMA Product Portfolio
  18. 6.3.5 Ionis Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Injections for SMA Sales by Country
  2. 7.1.1 North America Injections for SMA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Injections for SMA Sales by Country (2021-2026)
  4. 7.1.3 North America Injections for SMA Sales Forecast by Country (2027-2032)
  5. 7.2 North America Injections for SMA Market Size by Country
  6. 7.2.1 North America Injections for SMA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Injections for SMA Market Size by Country (2021-2026)
  8. 7.2.3 North America Injections for SMA Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Injections for SMA Sales by Country
  2. 8.1.1 Europe Injections for SMA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Injections for SMA Sales by Country (2021-2026)
  4. 8.1.3 Europe Injections for SMA Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Injections for SMA Market Size by Country
  6. 8.2.1 Europe Injections for SMA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Injections for SMA Market Size by Country (2021-2026)
  8. 8.2.3 Europe Injections for SMA Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Injections for SMA Sales by Country
  2. 9.1.1 Asia-Pacific Injections for SMA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Injections for SMA Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Injections for SMA Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Injections for SMA Market Size by Country
  6. 9.2.1 Asia-Pacific Injections for SMA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Injections for SMA Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Injections for SMA Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Injections for SMA Sales by Country
  2. 10.1.1 South America Injections for SMA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Injections for SMA Sales by Country (2021-2026)
  4. 10.1.3 South America Injections for SMA Sales Forecast by Country (2027-2032)
  5. 10.2 South America Injections for SMA Market Size by Country
  6. 10.2.1 South America Injections for SMA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Injections for SMA Market Size by Country (2021-2026)
  8. 10.2.3 South America Injections for SMA Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Injections for SMA Sales by Country
  2. 11.1.1 Middle East and Africa Injections for SMA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Injections for SMA Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Injections for SMA Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Injections for SMA Market Size by Country
  6. 11.2.1 Middle East and Africa Injections for SMA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Injections for SMA Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Injections for SMA Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Injections for SMA Value Chain Analysis
  2. 12.1.1 Injections for SMA Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Injections for SMA Production Mode & Process
  7. 12.2 Injections for SMA Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Injections for SMA Distributors
  10. 12.2.3 Injections for SMA Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research